CEDARS-SINAI MEDICAL CENTER

CEDARS-SINAI MEDICAL CENTER delivers advanced biomedical research and specialized laboratory services to federal agencies, with a focus on translational science and diagnostic innovation. Their core capabilities include the development and manufacturing of in-vitro diagnostic substances, operation of centralized omics and proteomic testing laboratories, and execution of complex life sciences research—particularly in stem cell therapeutics and tumor proteomics. The organization demonstrates deep technical expertise in clinical proteomic analysis, tissue sourcing for national research consortia, and the engineering of in-space biological production systems, positioning them as a niche provider at the intersection of clinical medicine and space biology. Their ability to integrate high-complexity laboratory workflows with federal research mandates distinguishes them in precision medicine and biologics development. The contractor has established sustained relationships with the Department of Health and Human Services, supporting national initiatives in cancer proteomics and genomic resource infrastructure, and has delivered specialized data migration and computational services to the Department of Veterans Affairs. They have also partnered with NASA on pioneering research into microgravity-enabled stem cell therapies, indicating a unique capacity to operate in extreme environmental research contexts. Their primary industry focus lies in in-vitro diagnostic manufacturing, testing laboratories, and life sciences R&D—areas requiring stringent regulatory compliance, clinical-grade sample handling, and high-throughput omics analysis. This positions them as a trusted provider for federally funded biomedical research programs requiring laboratory excellence and translational rigor. CEDARS-SINAI MEDICAL CENTER operates as a non-profit academic medical center headquartered in West Hollywood, California. While no formal government certifications are listed, their institutional reputation and operational infrastructure support compliance with federal research standards, including CLIA, CAP, and FDA regulatory frameworks. Their geographic presence and institutional credibility enable them to serve as a critical node in the federal life sciences ecosystem.